1. Regulatory Updates • CY 2027 Final Rule Issued: On April 2, 2026, CMS finalized the Contract Year 2027 Medicare Advantage (MA) and Part D rule. Key updates include streamlining Star Ratings and removing 11 administrative measures to focus on clinical outcomes and patient experience.
• Payment Rate Announcement: On April 6, 2026, CMS announced a 2.48% net average increase in MA plan payments for 2027. This exceeds the initial 0.09% estimate and totals over $13 billion more than 2026 funding levels.
• IRA Codification: CMS codified Inflation Reduction Act provisions for 2027. This eliminates the coverage gap, maintains the $2,100 out-of-pocket cap for 2026, and restructures the catastrophic phase.
• Agent Freedom: The rule removes several restrictions on the time and manner in which licensed agents and brokers conduct beneficiary conversations, aiming to reduce administrative friction.
2. Competitive Landscape • Carrier Retrenchment: For the 2026 plan year, UnitedHealthcare, Humana, and Aetna reduced their footprints. UnitedHealthcare exited 109 counties, while Humana exited 194 counties. This trend signals a shift toward prioritizing margin over broad geographic volume.
• Niche Expansion: In contrast, Elevance and Centene modestly expanded their county footprints. Special Needs Plans (SNPs) saw an increase of 281 plan offerings nationwide, even as general MA enrollment plans declined.
• Plan Availability: The average beneficiary currently chooses from 32 MA-PD plans, a decrease from 34 in 2025. Approximately 13% of enrollees faced plan terminations at the start of this year, a sharp increase from previous years.
3. Market Trends & Consumer Behavior • Benefit Contraction: While 98% of plans still offer dental, vision, and hearing, other supplemental benefits have declined. OTC allowances dropped from 73% to 66% of plans, and meal benefits fell from 65% to 57%.
• Premium Shifts: Weighted average premiums for general enrollment MA plans increased by nearly 22% (approx. $2.84) compared to 2025. However, zero-premium options remain available to 98% of beneficiaries.
• PPO Dominance: HMOs now account for 57% of plans, down from 71% in 2017. Local PPOs have grown to 42% of the market as consumers seek broader network flexibility.
4. Actionable Business Intelligence • Leverage Plan Terminations: Identify clients in counties where Humana or UnitedHealthcare exited. These individuals have special guaranteed issue rights for Medigap policies if they choose to return to Original Medicare.
• Pivot to SNPs: With SNP offerings increasing by nearly 20%, audit your lead lists for chronically ill beneficiaries. These plans often maintain more stable supplemental benefits (like OTC and transportation) than general MA plans. • Focus on Network Flexibility: Use the shift toward PPOs to explain value to clients. Highlight that while premiums rose 22% on average, PPOs provide the autonomy that many now prefer over restrictive HMO models.